Terns Pharmaceuticals (NasdaqGS:TERN) Earnings Call Presentation

TERN-701 CARDINAL Trial December 2025 Data Update DECEMBER 8, 2025 | NASDAQ: TERN Forward-looking Statements and Disclaimers This presentation contains forward-looking statements about Terns Pharmaceuticals, Inc. (the "Company," "we," "us," or "our") and its industry within the meaning of the federal securities laws that involve substantial risks and uncertainties. Forward-looking statements include statements related to or in connection with expectations, timing and potential results of clinical trials and ...